# Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant Patients

> **NCT03963999** · PHASE4 · WITHDRAWN · sponsor: **Children's Mercy Hospital Kansas City**

## Conditions studied

- Sinusoidal Obstruction Syndrome
- Veno Occlusive Disease, Hepatic
- Bone Marrow Transplant Complications
- Stem Cell Transplant Complications

## Interventions

- **DIAGNOSTIC_TEST:** Ultrasound Elastography
- **DRUG:** Contrast Enhanced Ultrasound (CEUS)

## Key facts

- **NCT ID:** NCT03963999
- **Lead sponsor:** Children's Mercy Hospital Kansas City
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-04-01
- **Primary completion:** 2024-04-30
- **Final completion:** 2025-04-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** We did not receive grant funding. We will reapply in June of 2020
- **Last updated:** 2020-01-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03963999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03963999, "Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant Patients". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT03963999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*